ProtocolsBiocompatible zwitterionic phosphorylcholine (cas 107-73-3) polymers with aggregation-induced emission feature

Add time:08/24/2019    Source:sciencedirect.com

Two novel zwitterionic phosphorylcholine (cas 107-73-3) polymers (MTP1 and MTP2) with aggregation-induced emission (AIE) feature were prepared through reversible addition fragmentation chain transfer polymerization between an AIE monomer with vinyl end group and a zwitterionic phosphorylcholine monomer. The synthesized copolymers were characterized and confirmed by 1H NMR, FT-IR, and X-ray photoelectron spectra. By introduction of the zwitterionic phosphorylcholine component, the synthesized copolymers showed amphiphilic properties and tended to self-assemble into fluorescent polymeric nanoparticles (FPNs) in water. The dynamic light scattering results indicated the size distribution of the MTP1 FPNs was 345 ± 22 nm, and that of the MTP2 FPNs was 147 ± 36 nm. The transmission electron microscopy results demonstrated spherical nanoparticle morphology for the FPNs. The high dispersibility of the FPNs in water was proved by the UV–vis absorption study with high transmittance of the solution. Fluorescent spectra of the prepared FPNs revealed bright green fluorescence with high fluorescence quantum yield of 45% for MTP1 and 34% for MTP2. More importantly, the FPNs showed excellent particle stability with low critical micelle concentration of 0.008 mg mL−1 for MTP1 and 0.007 mg mL−1 for MTP2. The cytotoxicity evaluation confirmed high cytocompatibility of the prepared FPNs at different concentrations, and demonstrated excellent biocompatibility for cell imaging. In virtue of the high-performance MTP1 and MTP2 FPNs, including high water dispersion, good particle stability, and excellent cytocompatibility, this work would inspire more researches about high-performance biocompatible fluorescent polymers for biomedical application.

We also recommend Trading Suppliers and Manufacturers of phosphorylcholine (cas 107-73-3). Pls Click Website Link as below: cas 107-73-3 suppliers

Prev:Optimisation of grafted phosphorylcholine (cas 107-73-3)-based polymer on additively manufactured titanium substrate for hip arthroplasty
Next:In situ surface modification on dental composite resin using 2-methacryloyloxyethyl phosphorylcholine (cas 107-73-3) polymer for controlling plaque formation)